Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer

One out of thirty cancer patients worldwide is diagnosed with cervical cancer [1] and the 5-year overall survival rate for the early stage group is 91% [2]. Half of all diagnosed cervical cancer patients is younger than 35 years [3], whereby late radiation-induced toxicities have a large influence on quality of life [4]. Thus, prevention of late radiation-induced side effects becomes increasingly relevant.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Original Article Source Type: research